House Sunscreen Bill Advances, But TEA Review Deadlines In Question
This article was originally published in The Rose Sheet
Executive Summary
The House Energy and Commerce Health subcommittee unanimously advanced the Sunscreen Innovation Act to full committee June 19, but provisions in the original bill seeking a tight timeline for FDA’s review of sunscreen ingredient time-and-extent applications are now in limbo, according to the Public Access to Sunscreens coalition of stakeholders.
You may also be interested in...
Sunscreen Bill Would Expedite TEA Decisions, Set Deadlines
The Sunscreen Innovation Act, introduced in both the House and the Senate, would streamline the process for FDA review of sunscreen TEAs and impose deadlines for agency action.
ICCS President Hill On Growing Regulatory Confidence In Alternative Testing Methodologies
In the year since its establishment, the International Collaboration on Cosmetics Safety has worked to engage with regulators as they build frameworks for assessing cosmetic safety without animal tests. ICCS president and CEO Erin Hill discusses current challenges and what lies ahead.
Hawaii Contemplates Measures To Increase Access To Sunscreens Following Sunscreen Bans
Hawaii looks to “ease the burden” of finding reef-safe sunscreens by distributing it to sunseekers at beaches. The proposed legislation comes roughly three years after the Aloha State began prohibiting sale of oxybenzone- or octinoxate-containing sunscreen products due to concerns about potential harm to coral.